Geneos Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4K | Sell |
210
-341
| -62% | -$42.9K | ﹤0.01% | 1898 |
|
|
2025
Q1 | $60.9K | Buy |
551
+457
| +486% | +$50.5K | ﹤0.01% | 1815 |
|
|
2024
Q4 | $12.8K | Hold |
94
| – | – | ﹤0.01% | 1942 |
|
|
2024
Q3 | $10.8K | Buy |
+94
| New | +$10.8K | ﹤0.01% | 1813 |
|
|
2024
Q2 | – | Sell |
-7
| Closed | -$965 | – | 2143 |
|
|
2024
Q1 | $965 | Buy |
+7
| New | +$965 | ﹤0.01% | 2027 |
|
|
2021
Q2 | – | Sell |
-11
| Closed | -$1K | – | 3022 |
|
|
2021
Q1 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 3041 |
|
|
2020
Q4 | – | Sell |
-50
| Closed | -$4K | – | 2962 |
|
|
2020
Q3 | $4K | Sell |
50
-250
| -83% | -$20K | ﹤0.01% | 2266 |
|
|
2020
Q2 | $39K | Sell |
300
-190
| -39% | -$24.7K | ﹤0.01% | 1327 |
|
|
2020
Q1 | $43K | Hold |
490
| – | – | ﹤0.01% | 1185 |
|
|
2019
Q4 | $53K | Buy |
+490
| New | +$53K | ﹤0.01% | 1220 |
|